Multi-organ Opioid Overdose Model

About Hesperos

Hesperos is a privately held, US-based biotech firm founded in 2015, specializing in advanced organ-on-a-chip systems. Its core technology involves interconnected, reconfigurable platforms that simulate the functional aspects of human organs, aiming to reduce animal testing and improve the predictability of drug development. The company operates a service-based business model, offering custom disease modeling and drug testing assays to research institutes and pharmaceutical partners. Hesperos is positioned as a leader in this niche field, leveraging strong academic foundations and intellectual property.

Therapeutic Areas